Cost

Wegovy Coupon Guide: What You Can Actually Save

GLP-1 Companion · 8 min read

A Wegovy coupon search usually means one thing: you are close to paying, and the number at the pharmacy does not feel real yet. The mistake is assuming the coupon alone answers the cost question. Wegovy cost depends on coverage, prior authorization, specialty pharmacy rules, savings-card terms, and refill timing.

My position: before you pay for any Wegovy path, know the month-one cost, month-three cost, and what happens if insurance denies the claim. If you still need a prescribing route, compare licensed provider options through /partners first.

The Wegovy Savings Offer: How It Works

Novo Nordisk offers a savings program for Wegovy that is structurally similar to the Ozempic offer but with different cost terms. For eligible commercially insured patients, the program caps monthly out-of-pocket costs at a set amount — historically $0 for the first month and approximately $200/month thereafter for patients whose insurance covers Wegovy, though exact terms have varied and should be verified at wegovy.com.

Unlike the Ozempic offer where patients can pay $25/month regardless of insurance coverage level, the Wegovy program's value depends heavily on whether your insurance covers the medication. The savings card offsets copays and coinsurance for covered patients — but if your insurance does not cover Wegovy at all, the card does not apply the full face-value discount.

Commercially Insured Patients: What the Savings Card Covers

For patients with commercial insurance that covers Wegovy (increasingly common since the 2023–2024 expansion of obesity medication coverage, including the Department of Defense TRICARE formulary addition), the savings card significantly reduces out-of-pocket costs.

• Month 1: Many patients pay $0 for the first fill under the introductory savings offer.
• Months 2+: Monthly out-of-pocket is capped — historically at $0–$200/month for insured patients depending on the specific program offer active at the time of fill.
• Annual savings limit applies: Novo Nordisk caps total annual savings, typically $3,600–$7,200 per year. Verify current terms at wegovy.com.
• The card is processed as a secondary payer after your insurance, so prior authorization requirements and formulary placement still apply.

Eligibility Requirements

The Wegovy savings offer has the same core eligibility structure as other Novo Nordisk programs with one critical additional restriction.

• You must have commercial insurance. Employer-sponsored plans, individual marketplace plans, and COBRA are eligible.
• Medicare Part D is excluded — by federal law, manufacturer savings cards cannot be used with Medicare Part D for any medication.
• Medicaid is excluded.
• TRICARE and other government insurance programs are excluded from the manufacturer card, even though TRICARE now covers Wegovy on formulary (TRICARE patients benefit from the negotiated TRICARE rate instead).
• You must be a US resident with a valid Wegovy prescription.
• Prior authorization or step therapy requirements do not disqualify you, but must be completed before the card can be applied.

What Happens When Insurance Denies Wegovy

Insurance denial for Wegovy is common, particularly on first submission. Denials frequently cite "not medically necessary," failure to meet BMI criteria, requirement for prior step therapy (attempting other weight loss interventions first), or exclusion of weight loss medications from the plan's formulary entirely.

When insurance denies Wegovy, your options include filing a formal appeal (your prescriber can assist with clinical documentation supporting medical necessity), having your prescriber submit a peer-to-peer review request, checking whether your employer's HR department can advocate for formulary inclusion, or exploring the alternatives below.

1. Step 1: Ask your prescriber's office to file a prior authorization with thorough clinical notes documenting BMI, weight-related comorbidities, and prior weight management attempts.
2. Step 2: If initially denied, request a formal first-level appeal. Include peer-reviewed evidence supporting Wegovy for your indication.
3. Step 3: If the first appeal is denied, request an external independent review (required by law for commercial insurance plans).
4. Step 4: If all appeals fail, consider whether switching to Ozempic (if you have Type 2 diabetes) or Zepbound might have better formulary coverage under your specific plan.

NovoCare: Income-Based Program for the Uninsured

For patients without commercial insurance, Novo Nordisk's NovoCare Patient Assistance Program is the primary route to affordable Wegovy. NovoCare provides free medication to qualifying uninsured or underinsured patients.

• Income eligibility: Household income at or below 400% of the federal poverty level (approximately $60,240 for a single adult, $124,000 for a family of four in 2026).
• Insurance requirement: Must be uninsured or have insurance that explicitly excludes coverage for the requested medication.
• Application: novonordisk-us.com/novocare or by calling 1-833-NOVO-411. Prescriber participation required.
• Processing: Allow 2–4 weeks. Some patients receive a small bridge supply while the application is reviewed.
• Annual renewal required with updated income documentation.

GoodRx for Wegovy: The Reality

GoodRx prices for Wegovy in early 2026 typically range from $1,200 to $1,350 per month — close to the list price, with limited discount. Because Wegovy is a specialty medication dispensed only through specialty pharmacies, the typical pharmacy price competition that drives GoodRx savings for common drugs is largely absent.

GoodRx for Wegovy is most useful as a comparison tool to identify which specialty pharmacy charges the lowest price, rather than as a meaningful coupon. The actual savings compared to list price are modest — typically $50–$150/month.

Specialty Pharmacy Requirements

Wegovy is dispensed exclusively through specialty pharmacies due to its specialty medication classification, cold-chain storage requirements, and the REMS (Risk Evaluation and Mitigation Strategy) program requirements that apply to some specialty medications. Your retail pharmacy corner store cannot dispense Wegovy — it must be fulfilled by a specialty pharmacy.

• Common specialty pharmacies that handle Wegovy: Walgreens Specialty, CVS Specialty (Caremark), Express Scripts (Accredo), OptumRx Specialty, and Novo Nordisk's own direct pharmacy program.
• Your insurance plan may require use of their preferred specialty pharmacy for coverage — using an out-of-network specialty pharmacy may result in higher costs or no coverage.
• Specialty pharmacies typically provide patient education, temperature-controlled shipping with ice packs, and refill reminder services.
• Allow 3–5 business days for specialty pharmacy processing and shipping, compared to same-day retail fills.

Actual Net Cost Scenarios in 2026

The following scenarios reflect typical actual costs patients experience for Wegovy in 2026.

• Commercially insured, Wegovy covered, savings card enrolled: $0 (first month) then $0–$200/month depending on program terms.
• Commercially insured, Wegovy NOT covered (no prior auth approval): $1,200–$1,350/month without other assistance.
• Medicare Part D: Wegovy is still not covered by most Medicare Part D plans for weight management in 2026 (CMS does not yet require obesity drug coverage). Some special needs plans and Advantage plans cover it — verify your specific plan.
• Uninsured, meets NovoCare income criteria: $0/month.
• Uninsured, does not meet NovoCare criteria: $1,200–$1,350/month (GoodRx provides minimal savings).
• TRICARE beneficiaries: Covered on TRICARE formulary since 2024; cost-sharing depends on TRICARE plan type (Prime, Select, For Life).

Key Takeaways

• The Novo Nordisk Wegovy Savings Offer can bring monthly costs to $0–$200 for eligible commercially insured patients.
• Medicare, Medicaid, and other government insurance programs are excluded from manufacturer savings cards.
• When insurance denies Wegovy, appeal with clinical documentation — many initial denials are overturned.
• GoodRx provides minimal savings for Wegovy compared to Ozempic, due to specialty pharmacy pricing dynamics.
• Uninsured patients with income at or below 400% of the federal poverty level may receive free Wegovy through NovoCare.
• Allow extra time for specialty pharmacy fulfillment; Wegovy cannot be dispensed at retail pharmacies.

The buyer move is to check the official savings terms, confirm prior authorization requirements, and compare provider options through /partners if you need a licensed path to evaluation and prescribing.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Wegovy (semaglutide) Prescribing Information. Novo Nordisk.